Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999
Open Access
- 1 December 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (6) , 1482-1487
- https://doi.org/10.1086/317477
Abstract
The objective of this study was to estimate the prevalence of and risk factors for clinical lipodystrophy (LD) and metabolic disorders in human immunKeywords
This publication has 30 references indexed in Scilit:
- Ritonavir, Triglycerides, and PancreatitisClinical Infectious Diseases, 1999
- “Buffalo hump” in HIV-1 infectionThe Lancet, 1998
- Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected PatientsClinical Infectious Diseases, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992